Clinical trial Recruiting at 1 site Interventional Ages 45 to 80

At-home ear vagus nerve stimulation plus computer brain training for thinking and mood

Official title: Combining At-Home Transcutaneous Auricular Vagus Nerve Stimulation and Computerized Cognitive Training for Neurocognitive Rehabilitation

Run by Medical University of South Carolina · NCT07517237 · Data updated 2026-11-12

This study will try at-home transcutaneous auricular vagus nerve stimulation combined with computerized cognitive training to see if it helps people aged 45-80 with self-reported cognitive changes improve thinking and mood.

Quick facts

Study typeInterventional
Ages45 Years to 80 Years
SexAll
Enrollment20 (estimated)
SponsorMedical University of South Carolina
Academic / other
Locations1 site (Charleston, South Carolina)
StatusRecruiting
StartedMarch 12, 2026
Main results expectedOctober 26, 2026
Study endsOctober 26, 2026
Registry record updatedOctober 23, 2026
Trial IDNCT07517237 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 45-80 with a self-reported change in cognition lasting at least six months that affects daily life, who have adequate sensorimotor and language ability, stable medications, reliable Wi‑Fi and a Bluetooth-enabled phone or tablet, and no prior diagnosis of MCI or dementia are ideal candidates.

Probably not a fit

People with a prior diagnosis of mild cognitive impairment or dementia, unstable medications, major sensory or motor impairments preventing device use, contraindications to taVNS, or who cannot travel to Charleston, SC for MRI and study visits are unlikely to benefit from or be eligible for this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a non-randomized, single-arm pilot of a 2-week at-home intervention pairing transcutaneous auricular vagus nerve stimulation (taVNS) with computerized cognitive training (CCT) in adults with subjective cognitive and psychosocial complaints. Participants self-administer the taVNS and complete CCT at home and undergo standardized cognitive and mood assessments before and after the treatment period. Brain MRI scans are obtained at baseline and after the intervention to explore treatment-related changes in brain function. The primary aims are to determine feasibility and acceptability and to collect preliminary data on cognitive, mood, psychosocial, and neural outcomes.

Why it matters

Potential benefit: If successful, this combined at-home approach could provide an accessible, noninvasive option to improve thinking, mood, and daily functioning without frequent clinic visits.

How similar studies have gone: Small studies of taVNS and of computerized cognitive training have shown mixed but sometimes promising effects separately, while the specific combination used here is novel and largely untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

i. Ages 45-80 (inclusive) ii. Adequate sensorimotor function (including motor function of dominant hand to complete CCT) and verbal expressive abilities to complete all assessments.

iii. Access to reliable Wi-Fi and a Bluetooth-enabled mobile phone or tablet with internet connection capable of supporting study procedures.

iv. Self-reported change in cognitive functioning (e.g., memory, attention, thinking abilities) compared to prior functioning, persisting ≥ 6 months and associated with concern and/or impact on daily functioning.

v. Is on fixed pharmacotherapy (i.e. stable dose of medication/s) for ≥ 4 weeks before enrollment, and expected to remain stable throughout study participation. This includes, but is not limited to, cholinesterase inhibitors, NMDA receptor antagonists, and antidepressants.

Exclusion Criteria:

i. Prior diagnosis of Mild Cognitive Impairment or Dementia (NIA-AA) or Mild or Major Neurocognitive Disorder (DSM-5).

ii. taVNS contraindications (e.g., history of seizures, history of trauma or damage to ear, reduced/impaired sensation in the ear).

iii. MRI contraindications (e.g., ferromagnetic implants, claustrophobia). iv. Presence of a neurological, medical, or psychiatric condition that is acute, unstable, or severe, and that, in the judgment of the study investigators, would significantly interfere with safe participation, valid assessment of cognition or mood, or interpretation of study outcomes.

v. Enrolled in a clinical trial or has received an investigational medication or device in the last 30 days that may impact cognition or mood.

vi. For female participants, a positive pregnancy test if still menstruating within the past 12 months.

Where it's running

  • Medical University of South Carolina
    Charleston, South Carolina, United States
    Recruiting

Study contacts

  • Principal investigator: Stephanie Aghamoosa, PhD — Medical University of South Carolina

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.